| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.2913 | 29 |
| GSM780708 | Untreated after 4 days (C2_1) | 41.9865 | 13 |
| GSM780709 | Untreated after 4 days (C3_1) | 42.0948 | 13 |
| GSM780719 | Untreated after 4 days (C1_2) | 48.4939 | 43 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.4692 | 20 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.0508 | 18 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 41.0964 | 10 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.8447 | 51 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.3149 | 29 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 39.4166 | 5 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.4972 | 50 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.5274 | 20 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.9621 | 37 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 38.6051 | 3 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 37.8295 | 2 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.7036 | 40 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.4309 | 11 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.2709 | 23 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.5265 | 25 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 37.8387 | 2 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 42.0694 | 13 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.3978 | 24 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.1912 | 28 |